IRIS
ALGERI, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.117
SA - Sud America 781
NA - Nord America 461
EU - Europa 289
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.698
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 603
US - Stati Uniti d'America 422
SG - Singapore 406
VN - Vietnam 381
CN - Cina 177
IT - Italia 87
AR - Argentina 73
DE - Germania 54
EC - Ecuador 54
ID - Indonesia 32
GB - Regno Unito 28
BD - Bangladesh 25
CO - Colombia 21
NL - Olanda 21
AT - Austria 19
FI - Finlandia 19
MX - Messico 18
IN - India 16
RU - Federazione Russa 14
ZA - Sudafrica 14
MA - Marocco 13
UA - Ucraina 12
CA - Canada 11
PK - Pakistan 11
HK - Hong Kong 10
PY - Paraguay 10
IQ - Iraq 9
PL - Polonia 9
CL - Cile 8
KE - Kenya 8
SA - Arabia Saudita 8
FR - Francia 6
VE - Venezuela 6
TR - Turchia 5
DZ - Algeria 4
EG - Egitto 4
ES - Italia 4
IL - Israele 4
KZ - Kazakistan 4
PE - Perù 4
TN - Tunisia 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
IE - Irlanda 3
IR - Iran 3
QA - Qatar 3
TW - Taiwan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
NP - Nepal 2
PA - Panama 2
SE - Svezia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
JP - Giappone 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
RE - Reunion 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.698
Salva come PNG Salva come JPEG
Città #
Singapore 218
Santa Clara 154
Hefei 149
Ho Chi Minh City 143
Dallas 101
Hanoi 84
Munich 34
São Paulo 33
Ashburn 29
Beijing 23
Haiphong 23
Rome 20
Guayaquil 19
Rio de Janeiro 17
Quito 14
Da Nang 13
Helsinki 12
Nuremberg 12
Thái Bình 12
Biên Hòa 11
London 11
Milan 11
Hong Kong 10
Boardman 9
Curitiba 9
Guarulhos 9
Hải Dương 9
Ribeirão Preto 9
Thái Nguyên 9
Belo Horizonte 8
Buenos Aires 8
Campinas 8
Johannesburg 8
New York 8
Palermo 8
Amsterdam 7
Fortaleza 7
Goiânia 7
Nairobi 7
Uberlândia 7
Bogotá 6
Brasília 6
Dhaka 6
Ourinhos 6
Porto Alegre 6
Salvador 6
Turku 6
Vallefiorita 6
Warsaw 6
Baghdad 5
Bauru 5
Cape Town 5
Ha Long 5
Lấp Vò 5
Medellín 5
Ninh Bình 5
Quảng Ngãi 5
Recife 5
Santo André 5
Asunción 4
Belém 4
Boydton 4
Brooklyn 4
Bắc Ninh 4
Can Tho 4
Ciudad del Este 4
Islington 4
Joinville 4
Juiz de Fora 4
Los Angeles 4
Mauá 4
Osasco 4
Quận Chín 4
Riyadh 4
San Francisco 4
San Nicola Manfredi 4
Toronto 4
Viamão 4
Vitória da Conquista 4
Allen 3
Ankara 3
Araras 3
Baku 3
Bandung 3
Bento Gonçalves 3
Birigui 3
Boston 3
Bình Dương 3
Camaçari 3
Caraguatatuba 3
Corrientes 3
Córdoba 3
Doha 3
Formosa 3
Franca 3
Gavoi 3
Jakarta 3
Juazeiro 3
Krasnodar 3
Lauro de Freitas 3
Totale 1.537
Salva come PNG Salva come JPEG
Nome #
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL 49
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma 46
In vitro Cytotoxic Effect of Trabectedin on JMML AND CMML Cell Populations 44
Betibeglogene autotemcel gene therapy for non–β0/β0 genotype β-thalassemia 35
Autologous gene therapy for hemoglobinopathies: From bench to patient's bedside 33
Outcomes of children and young adults with B-cell acute lymphoblastic leukemia given blinatumomab as last consolidation treatment before allogeneic hematopoietic stem cell transplantation 31
Availability of HLA-allele-matched unrelated donors and registry size: Estimation from haplotype frequency in the Italian population 31
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 30
FINAL RESULTS OF THE PHASE 3 STUDIES NORTHSTAR-2 AND NORTHSTAR-3 IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA (TDT): SUBGROUP ANALYSIS OF ITALIAN PATIENTS TREATED WITH BETIBEGLOGENE AUTOTEMCEL (BETI-CEL), LENTIGLOBIN FOR THALASSEMIA 29
GENERATION OF CYTOTOXIC T LYMPHOCYTES BY DONOR-SPECIFIC CSE PEPTO WT1 AND WITH CYTOTOXIC ACTIVITY TOWARDS LEUKEMIC BLASTS OF THE PATIENT FOR ADOPTIVE IMMUNOTHERAPY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS. 29
T-cell depleted HLA-haploidentical HSCT in a child with neuromyelitis optica 28
TCRab/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders 28
Alpha/beta T-cell depleted Haploidentical HSCT followed by infusion of donor lymphocytes transduced with inducible caspase9 gene is safe and effective for patients with erythroid disorders 28
IMPACT OF POST-TRANSPLANT INFUSION OF DONOR T CELLS GENETICALLY MODIFIED WITH INDUCIBLE CASPASE 9 SUICIDE GENE (BPX-501 CELLS) ON CHILDREN WITH LEUKEMIA GIVEN ALPHA-BETA T-CELL DEPLETED HAPLO-HSCT 27
Comprehensive characterization of bone-marrow mesenchymal stromal cells isolated from patients affected by primary immunodeficiency 27
CAR.CD123-NK Cells Have an Equally Effective but Safer Off-Tumor/on-Target Profile As Compared to CARCD123-T Cells for the Treatment of Acute Myeloid Leukaemia 27
T-Cell Depleted HLA-Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (haplo-HSCT) Followed By Donor Lymphocyte Infusion with T Cells Transduced with the Inducible Caspase 9 (iC9) Suicide Gene in Children with Hematological Malignancies 27
TCRαβ +/CD19 + - Depleted HLA-Haploidentical Hematopoietic Stem Cell Traansplantation in Pediatric Patient with Fanconi Anemia 27
Achievement of operational tolerance in a pediatric liver transplant recipient following successful hematopoietic stem cell transplantation from a different donor 27
Use of emapalumab in the peri-transplant period to prevent graft failure in patients at risk 27
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 26
Engineered mucoperiosteal scaffold for cleft palate regeneration towards the non-immunogenic transplantation 25
Decellularized esophageal tubular scaffold microperforated by quantum molecular resonance technology and seeded with mesenchymal stromal cells for tissue engineering esophageal regeneration 25
Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease 25
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells isolated from pediatric patients affected by acute myeloid leukemia 25
Autologous CD19‐Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis 24
Outcome of children with acute leukemia given allogeneic HSCT either from an unrelated donor (UD-HSCT) or from an HLA-partially matched relative after αß-T cell/B-cell depletion (αßhaplo-HSCT) 24
Outcome of children with ALL in second complete remission transplanted from an unrelated donor: a retrospective analysis 24
A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome 24
Management of pediatric patients with anti-HLA antibodies undergoing T-cell depleted haploidentical hematopoietic stem cell transplantation 24
Cord blood transplantation for acute leukemia 24
ABATACEPT REDUCES ACUTE GVHD INCIDENCE IN PEDIATRIC PATIENTS TRANSPLANTED FROM HLA-MISMATCHED UNRELATED DONORS 23
Outcome of Children with Acute Leukemia Given Allogeneic HSCT Either from an Unrelated Donor or from an HLA-Partially Matched Relative after αβ-T Cell/B-Cell Depletion: A Multicenter, Retrospective, Comparative Analysis of the AIEOP Network 23
THE USE OF BPX-501 DONOR T CELL INFUSION (WITH INDUCIBLE CASPASE 9 SUICIDE GENE) TOGETHER WITH HLA-HAPLOIDENTICAL STEM CELL TRANSPLANT TO TREAT CHILDREN WITH HEMOGLOBINOPATHIES AND ERYTHROID DISORDERS 23
BPX-501 DONOR T CELL INFUSION (WITH INDUCIBLE CASPASE 9 SUICIDE GENE) FACILITATES HLA-HAPLOIDENTICAL STEM CELL TRANSPLANT IN CHILDREN WITH BOTH HEMATOLOGICAL MALIGNANCIES AND NON-MALIGNANT CONDITIONS 23
T Cell-Depleted and T Cell-Replete HLA-Haploidentical Stem Cell Transplantation for Non-malignant Disorders 23
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia 23
A new promising, third-generation (3RD) CAR-CD30 T cells therapy for CD30+lymphoma patients 23
Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) in Children with Myelodysplastic Syndromes 22
Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors 22
P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL 22
A new BSA-based Threshold Predicts Optimal PBSC Collection in T-cell Depleted HLA-haploidentical Stem Cell Transplantation 21
The Development of New Agents for Post-Hematopoietic Stem Cell Transplantation Non-Infectious Complications in Children 21
Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy 21
Natural history of Ras‐associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progression 21
Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter Study 21
Alpha/Beta T-Cell and B-Cell Depletion HLA-Haploidentical Hematopoietic Stem Cell Transplantation Is an Effective Treatment for Children/Young Adults with Acute Leukemia 21
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia 21
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia 21
Donor T Cells Genetically Modified with a Novel Suicide Gene (inducible Caspase 9, iC9) Expand and Persist over Time after Post-Allograft Infusion in Patients Given αβ T-Cell and B-Cell Depleted HLA-Haploidentical Allogeneic Stem Cell Transplantation (αβ haplo-HSCT) Contributing to Accelerate Immune Recovery 21
Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia 21
Remestemcel-L for the treatment of graft versus host disease 21
Decolonization of multi-drug resistant bacteria by fecal microbiota transplantation in five pediatric patients before allogeneic hematopoietic stem cell transplantation: Gut microbiota profiling, infectious and clinical outcomes 21
Circulating Extracellular Vesicles Impair Mesenchymal Stromal Cell Differentiation Favoring Adipogenic Rather than Osteogenic Differentiation in Adolescents with Obesity 21
Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (Tbdepl-Haplohsct) in Children with Non-Malignant Disorders 21
Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia 20
Treosulfan Exposure in Pediatric Hematopoietic Stem Cell Transplantation is Associated with Early Toxicity but not with event-free Survival 20
NIRMATRELVIR/RITONAVIR AND TIXAGEVIMAB/CILGAVIMAB AS SARS-COV-2 TREATMENT IN PEDIATRIC AND YOUNG ADULT PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) OR CD19-DIRECTED CAR T-CELL TREATMENT 20
Administration of BPX-501 Cells Following Αβ T and B-Cell-Depleted HLA-Haploidentical HSCT (haplo-HSCT) in Children with Malignant or Non-Malignant Disorders 20
Outcomes of children with primary immunodeficiencies receiving alpha/beta T-cell depleted HLA-haplo-HSCT followed by infusion of lymphocytes transduced with the inducible caspase 9 (iC9) suicide gene 20
T- and B-Cell Neogenesis Recovers Efficiently in Children with Acute Leukemia Given an Alpha-Beta T-Cell Depleted Haplo-HSCT Followed By Infusion of Donor T-Cells Genetically Modified with Inducible Caspase 9 Suicide Gene (BPX-501 cells) 20
Unmanipulated donor lymphocyte infusion (dli) after ab-t and b-cell depleted haploidentical stem cell transplantation 20
Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Cerebral Adrenoleukodystrophy: Outcomes by Donor Cell Source And Match, Conditioning Regimen, And Stage of Cerebral Disease 20
Results of a Multicentre, Randomized, Controlled Open-Label Study on the Use of Anti-T-Lymphocyte Globulin (ATLG) and Rituximab for Immunomodulation of Graft-Versus-Host Disease (GvHD) and Graft Failure (GF) in Patients with Non-Malignant Disorders 20
Current and future role of bispecific T-cell engagers in pediatric acute lymphoblastic leukemia 20
Use of Ruxolitinib in Pediatric Patients with Steroid-Refractory Graft-versus-host Disease (GVHD) 20
Long-Term Outcome of Children with Acute Leukemia (AL) Given Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) 20
Allogeneic CD19-CAR T cells: a promising treatment for pediatric patients with highly refractory BCP-ALL relapsing after allogeneic hematopoietic stem cells transplant (allo-HSCT) 19
Improved T- and B-Cell Neogenesis in Children with Acute Leukemia Given an Alpha-Beta T-Cell Depleted Haplo-HSCT Combined with the Infusion of Donor T-Cells Genetically Modified with Inducible Caspase 9 Suicide Gene (Rivo-cel) 19
Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Transfusion-Dependent β-Thalassemia Treated at the Bambino Gesù Children's Hospital, Rome, Italy 19
Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL) 19
Anti-T-Lymphocyte Globulin (ATLG) and Rituximab for Immunomodulation of Graft-Versus-Host Disease and Graft Failure in Patients with Non-Malignant Disorders: Results of a Multicentre, Randomized, Open-Label Study 19
Bispecific Antibodies and Other Non-CAR Targeted Therapies and HSCT: Decreased Toxicity for Better Transplant Outcome in Paediatric ALL? 19
Brentuximab in Children, Adolescent and Young Adults with Relapsed/Refractory Anaplastic Large Cell Lymphoma 19
NK Cells and PMN-MDSCs in the Graft From G-CSF Mobilized Haploidentical Donors Display Distinct Gene Expression Profiles From Those of the Non-Mobilized Counterpart 18
Academic, Phase I/II Trial on T Cells Expressing a Second Generation, CD19-Specific Chimeric Antigen Receptor (CAR) and Inducible Caspase 9 Safety Switch for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) and B-Cell Non-Hodgkin Lymphoma (B-NHL) in Children 18
Outcome of Children with Different Non-Malignant Disorders Given Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) 18
HLA-haploidentical TCRab1/CD191-depleted stem cell transplantation in children and young adults with Fanconi anemia 18
Unrelated donor vs HLA-haploidentical a/b T-cell– and B-cell–depleted HSCT in children with acute leukemia 18
Busulfan–fludarabine- or treosulfan–fludarabine-based myeloablative conditioning for children with thalassemia major 18
Genome editing for sickle cell disease: still time to correct? 18
SUCCESS OF PERSONALIZED RUXOLITINIB TREATMENT BASED ON THERAPEUTIC DRUG MONITORING IN PEDIATRIC PATIENTS WITH PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS ALLOWING BRIDGING TO HSCT 17
Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity 17
Characterization of Bone Marrow Infiltrate of Immune-mediated Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation 17
Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia 17
Dissecting the mechanisms of bone loss in Gorham-Stout disease 17
TCRαβ/CD19 cell–depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis 17
Outcome of Children with Wiskott-Aldrich Syndrome (WAS) Given TCR Alpha-Beta/CD19 Depleted Hematopoietic Stem Cell Transplantation (HSCT) from an HLA-Haploidentical Relative 17
Pre-Transplant Levels of Multiparametric Flow-Cytometry Measurable Residual Disease (MFC-MRD) Predict Outcomes in Children with Acute Myeloid Leukemia Given Allogeneic Hematopoietic Stem Cell Transplantation 17
Mucosal-Associated Invariant T (MAIT) Cells Are Functionally Impaired in Pediatric Patients Following HCT and Their Recovery Is Associated with the Onset of GvHD 17
CD19 REDIRECTED CAR NK CELLS ARE EQUALLY EFFECTIVE BUT LESS TOXIC THAN CAR T CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA 17
Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision model 17
Gata2 related conditions and predisposition to pediatric myelodysplastic syndromes 17
HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties 16
Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia 16
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient 16
Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study 16
Reconstitution Dynamics and Impact on Clinical Outcomes of Mucosal-Associated Invariant T-Cells in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation 16
Hematopoietic Stem Cell Transplantation in Thalassemia 16
Phenotypic and functional characterization of mesenchymal stromal cells isolated from pediatric patients with severe idiopathic nephrotic syndrome 16
Totale 2.236
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.399
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 0 0 0 12 0
2024/20251.185 4 0 3 402 66 165 60 29 95 70 59 232
2025/20261.700 75 395 813 417 0 0 0 0 0 0 0 0
Totale 2.897